Soleno Therapeutics announces appointments to its leadership team

Soleno Therapeutics (SLNO) announced the appointments of Meredith Manning, M.B.A as Chief Commercial Officer, Dairine Dempsey, Ph.D. as Vice President, Europe and Lauren Budesheim, M.S. as Vice President of Human Resources. The Company also announced the appointment of key advisors with Shamim Ruff, M.S. joining as Chair of the Development Advisory Board and James Geraghty, J.D., M.S. as a Board Advisor. Prior to joining Soleno, Meredith Manning served as President of the Americas and a member of the U.S. Board of Directors at PharmaEssentia. Dairine Dempsey has been a consultant to Soleno since 2019. Lauren Budesheim previously served as Head of People at Neurona Therapeutics. Shamim Ruff is currently the Chief Regulatory Affairs Officer and SVP, Head of Quality Assurance at Stoke Therapeutics (STOK). James Geraghty serves as the Chairman of the Board of Directors for Orchard Therapeutics (ORTX), Pieris Pharmaceuticals (PIRS) and OMass Therapeutics.